Animal StudyResults in animals only. May or may not translate to humans.Skin Barrier DamagePublished: March 7, 2026
MDBA May Help Alleviate Atopic Dermatitis Symptoms
Researchers studied a combination of four ingredients called MDBA to see if it could help alleviate symptoms of atopic dermatitis, a condition that affects the skin's barrier and immune system. In lab experiments and animal studies, MDBA showed promise in reducing inflammation and improving skin barrier function. However, more research is needed to confirm these findings.
Why it matters: Understanding how MDBA works could lead to new treatments for atopic dermatitis, a condition that affects millions of people worldwide.
This study was conducted in lab experiments and animal models, and its findings may not translate to humans. Further research is needed to confirm the efficacy and safety of MDBA in people with atopic dermatitis.
Small Human StudySmall or uncontrolled human study. Results are preliminary.AcnePublished: March 1, 2026
Amino Acid Cleanser May Help Improve Acne and Oily Skin
Researchers studied an amino acid cleanser containing salicylic acid, glucuronolactone, and ceramides for 28 days. They found that it may help improve skin barrier function, reduce acne, and improve skin texture and moisture content. However, more research is needed to confirm these findings.
Why it matters: This study may help skincare experts understand how certain ingredients can improve acne and oily skin conditions.
A small sample size of 42 volunteers was used, and the study only lasted for 28 days.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Skin Barrier DamagePublished: March 1, 2026
Ceramides with longer acyl chains may improve skin barrier function
Researchers studied how different lengths of ceramide molecules affect human skin barrier recovery and hydration. They found that ceramides with longer acyl chains may be more effective at improving skin barrier function. However, more research is needed to confirm these findings.
Why it matters: Understanding how ceramide acyl chain length affects skin barrier function may lead to better skincare products for improving skin hydration and barrier recovery.
This study had a small sample size and was a controlled trial, but the sample size was not specified. The study only tested two different ceramide formulations, and more research is needed to confirm these findings.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Skin Barrier DamagePublished: March 1, 2026
Skin Barrier Dysfunction in Contact and Atopic Dermatitis
Researchers studied how skin barrier dysfunction contributes to contact dermatitis and atopic dermatitis. They found that restoring the skin barrier may be a key therapeutic approach. However, compliance with barrier-enhancing interventions remains a challenge.
Why it matters: Understanding skin barrier dysfunction may help improve treatment options for people with contact dermatitis and atopic dermatitis.
This review is based on existing research and does not present new findings. The effectiveness of barrier-enhancing interventions in occupational settings is still a challenge.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Sensitive SkinPublished: February 27, 2026
Ceramide NP C15 Emollient May Help Improve Sensitive Skin Symptoms
Researchers studied a ceramide-containing emollient to see if it could help people with sensitive skin. They found that it may improve skin barrier function and reduce symptoms. However, the study was small and more research is needed to confirm these findings.
Why it matters: Understanding how to improve skin barrier function and reduce symptoms in sensitive skin could lead to better skincare treatments.
A small, six-week study with 50 participants, and the results are exploratory, suggesting further investigations are needed.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.PhotoagingPublished: February 24, 2026
Probiotics may help with skin aging and conditions in older adults
Researchers studied how probiotics affect skin aging and conditions in older adults. They found that probiotics may help restore balance to the skin's microbiome, improve skin barrier function, and reduce inflammation. However, more research is needed to confirm these findings.
Why it matters: Understanding the potential benefits of probiotics for skin health in older adults could lead to new strategies for managing age-related skin changes.
Several challenges remain regarding strain specificity, formulation stability, regulatory constraints on viable organisms, and the paucity of adequately powered randomized clinical trials.
Animal StudyResults in animals only. May or may not translate to humans.Skin Barrier DamagePublished: February 5, 2026
GLTP Gene Mutations Linked to Skin Scaling Disorder
Researchers studied a rare skin condition called nonsyndromic epidermal differentiation disorder, which causes skin scaling. They found that mutations in the GLTP gene may be responsible for this condition. The GLTP gene helps transport a type of skin lipid called glucosylceramide.
Why it matters: Understanding the role of the GLTP gene may help researchers develop new treatments for skin scaling disorders.
This study was conducted in lab experiments using mice and has not been tested in humans. Further research is needed to confirm these findings and explore potential treatments.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Dry SkinPublished: February 1, 2026
Body Lotion May Help Improve Dry Skin Symptoms
A small study looked at whether a body lotion with ceramides and natural oils can help alleviate dry skin symptoms. Researchers found that the lotion may improve skin hydration, radiance, and smoothness, and reduce dryness and scaling. However, more research is needed to confirm these findings.
Why it matters: This study provides insight into how a specific body lotion may affect the skin's lipid balance and microbial community, which could be useful for understanding dry skin and developing new treatments.
This study was a small, self-controlled trial with a short duration of 4 weeks, and more research is needed to confirm its findings.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Sensitive SkinPublished: February 1, 2026
Indian Dermatologists' Views on Sensitive Skin and Colloidal Oats
A small study surveyed 150 Indian dermatologists about their knowledge and practices in treating sensitive skin. Researchers found that most dermatologists emphasize the importance of moisturizers and skin barrier reinforcement. Colloidal oatmeal was identified as a helpful ingredient for skin barrier repair.
Why it matters: Understanding how dermatologists manage sensitive skin may help individuals with similar skin concerns make informed decisions about their skincare routines.
This study is a cross-sectional survey and may not reflect the views of all dermatologists. The sample size is relatively small, and awareness among non-prescribers of colloidal oatmeal-based products was limited.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Skin Barrier DamagePublished: January 20, 2026
Acid Ceramidase ASAH1 Regulates Skin Barrier Function
Researchers studied how a specific enzyme called acid ceramidase ASAH1 affects the skin's barrier function. They found that ASAH1 helps break down certain types of ceramides, which are important for skin health. This process may play a role in maintaining healthy skin, but more research is needed to fully understand its effects.
Why it matters: Understanding how ASAH1 regulates ceramide levels may help us better understand skin health and potentially develop new skincare treatments.
The study used immortalized human keratinocytes and was conducted in a lab setting, so its findings may not directly translate to real-world skin conditions. Further research is needed to confirm these results in a larger, more diverse population.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Skin Barrier DamagePublished: January 19, 2026
Capecitabine Side Effect May Affect Skin Barrier Function
Researchers studied how a chemotherapy medication called capecitabine affects the skin's barrier function. They found that it may alter the structure and composition of the skin's outer layer, leading to changes in how the skin protects itself. This could be related to a side effect called hand-foot syndrome.
Why it matters: Understanding how capecitabine affects the skin may help researchers develop new treatments for skin problems related to chemotherapy.
This study involved only 11 patients with hand-foot syndrome and was based on a small sample size. The results may not be generalizable to other patients or skin conditions.
In VitroCell or tissue culture experiments. No human or animal data.Skin Barrier DamagePublished: January 9, 2026
Ceramide Headgroup Chemistry Affected Skin Barrier Lipid Organization in Simulations
Using coarse-grained and atomistic molecular dynamics simulations, researchers studied how different ceramide headgroups influence hydrogen bonding and structural organization in stratum corneum lipid mixtures. The work showed that ceramide chemistry and chain-length distribution can alter barrier-related lipid behavior. This helps explain how barrier composition influences permeability and structure.
Why it matters: Barrier function depends strongly on lipid organization, so mechanistic studies like this can inform how ceramide-focused products are designed and interpreted.
This was a simulation and model-based study rather than a clinical evaluation of a skincare product in humans.